The Things to Think About Before Taking Your Biotech Company Public
The biotech IPOs window is now open, but that doesn’t mean every company can go…
The Things to Think About Before Taking Your Biotech Company Public
The biotech IPOs window is now open, but that doesn’t mean every company can go through it. A panel at the BIO Convention in San Diego discussed the steps biotech companies should take if they’re considering a public listing. The post The Things to Think About Before Taking Your Biotech Company Public appeared first on…
Cadence Rakes In $100M to Automate Chronic Care at Scale
Cadence raised $100 million in Series C funding to scale its AI-powered chronic care platform, which monitors patients at home and adjusts their medications in real time.The startup, now valued at $1.23 billion, partners with health systems to treat patients with heart failure, hypertension and diabetes. The post Cadence Rakes In $100M to Automate Chronic…
Startup Raises $7M for Virtual-First Pediatric Therapy Model
Ladder Health’s seed round was led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, 25madison Health, Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital and 7Rock Ventures. The post Startup Raises $7M for Virtual-First Pediatric Therapy Model appeared first on MedCity News.
U.S. Global Health Legislation Tracker
This tracker provides a listing of global health-related legislation introduced in the current Congress.
The Medical Frailty Exemption from Medicaid Work Requirements: Key Takeaways from the CMS Interim Final Rule
This brief describes new guidance and potential challenges states will face in operationalizing the medical frailty exemption.
Why Healthcare AI is Missing the Point
Organizations that are experiencing significant improvements related to AI are not necessarily using more advanced tools. They are just using the tools they have with more intention. The post Why Healthcare AI is Missing the Point appeared first on MedCity News.
Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers
Providers don’t need to endorse ibogaine treatment to take this moment seriously. They need to understand it, respect the risk, and prepare for those already seeking it. The post Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers appeared first on MedCity News.
Washington’s Medical Debt Push Risks Missing the Bigger Healthcare Crisis
This is not an abstract discussion. It is about sustaining the organizations, employees, and communities that depend on us. If we fail to account for how these policies interact in the real world, we risk weakening the very system we are trying to improve. The post Washington’s Medical Debt Push Risks Missing the Bigger Healthcare…
Why So Few Appeals Happen and What That Reveals About Health Plans
Appeals and grievances reflect how well a health plan functions under pressure. They also show how effectively your organization can surface, prioritize, and resolve the cases that matter most. The post Why So Few Appeals Happen and What That Reveals About Health Plans appeared first on MedCity News.
Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
Bill Curry, 65, raises cattle on the same land in rural Oklahoma once owned by his father and generations before him. Each quarter, for several years, he has made the 2½-hour drive to Oklahoma City for an epidural in his spine to treat his back pain. But this year, because of a new Medicare program,…
